Department of Otolaryngology, Head and Neck Surgery, Institute of Otolaryngology, Genetic Testing Center for Deafness, Chinese PLA General Hospital, Beijing, China.
National Clinical Research Center for Otolaryngologic Diseases, Beijing, China.
Am J Med Genet A. 2020 Jun;182(6):1438-1448. doi: 10.1002/ajmg.a.61583. Epub 2020 Apr 7.
Multiple synostoses syndrome (SYNS1; OMIM# 186500) is a rare autosomal dominant disorder reported in a few cases worldwide. We report a Chinese pedigree characterized by proximal symphalangism, conductive hearing loss, and distinctive facies. We examined the genetic cause and reviewed the literature to discuss the pathogeny, treatment, and prevention of SYNS1. Audiological, ophthalmological, and radiological examinations were evaluated. Whole-exome sequencing (WES) was performed to identify mutations in the proband and her parents. Sanger sequencing was used to verify the results for the proband, parents, and grandmother. The literature on the genotype-phenotype correlation was reviewed. The patient was diagnosed with multiple synostoses syndrome clinically. WES and bioinformatic analysis revealed a novel missense mutation in the NOG gene, c.554C>G (p.Ser185Cys), cosegregated in this family. The literature review showed that the phenotype varies widely, but the typical facies, conductive hearing loss, and proximal symphalangism occurred frequently. All reported mutations are highly conserved in mammals based on conservation analysis, and there are regional hot spots for these mutations. However, no distinct genotype-phenotype correlations have been identified for mutations in NOG in different races. Regular systematic examinations and hearing aids are beneficial for this syndrome. However, the outcomes of otomicrosurgery are not encouraging owing to the regrowth of bone. This study expanded the mutation spectrum of NOG and is the first report of SYNS1 in a Chinese family. Genetic testing is recommended as part of the diagnosis of syndromic deafness. A clinical genetic evaluation is essential to guide prevention, such as preimplantation genetic diagnosis.
多发性骨融合综合征(SYNS1;OMIM# 186500)是一种罕见的常染色体显性遗传病,全球报道的病例较少。我们报道了一个中国家系,其特征为近侧指(趾)间关节融合、传导性听力损失和独特的面容。我们探讨了遗传病因,并复习文献讨论 SYNS1 的发病机制、治疗和预防。评估了听力学、眼科和影像学检查。对先证者及其父母进行了全外显子组测序(WES)以寻找突变。对先证者、父母和祖母进行了 Sanger 测序以验证结果。对基因型-表型相关性的文献进行了综述。临床诊断患者为多发性骨融合综合征。WES 和生物信息学分析发现 NOV 基因中的一个新错义突变,c.554C>G(p.Ser185Cys),在家系中共同遗传。文献复习显示,表型差异很大,但典型的面容、传导性听力损失和近侧指(趾)间关节融合较常见。基于保守性分析,所有报道的突变在哺乳动物中高度保守,这些突变存在区域性热点。然而,不同种族的 NOV 基因突变与表型之间没有明显的相关性。定期进行系统检查和佩戴助听器对此综合征有益。然而,由于骨的再生,耳显微骨手术的结果并不理想。本研究扩展了 NOV 的突变谱,也是中国家系多发性骨融合综合征的首次报道。建议对综合征性耳聋进行基因检测。临床遗传评估对于指导预防(如植入前遗传诊断)至关重要。